[go: up one dir, main page]

WO2019088958A3 - Utilisation du genêt épineux en tisane pour le traitement du diabète - Google Patents

Utilisation du genêt épineux en tisane pour le traitement du diabète Download PDF

Info

Publication number
WO2019088958A3
WO2019088958A3 PCT/TR2018/050591 TR2018050591W WO2019088958A3 WO 2019088958 A3 WO2019088958 A3 WO 2019088958A3 TR 2018050591 W TR2018050591 W TR 2018050591W WO 2019088958 A3 WO2019088958 A3 WO 2019088958A3
Authority
WO
WIPO (PCT)
Prior art keywords
jerusalem
herbal tea
diabetes treatment
thorn
fruits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050591
Other languages
English (en)
Other versions
WO2019088958A2 (fr
Inventor
Kasim TAKIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2019088958A2 publication Critical patent/WO2019088958A2/fr
Publication of WO2019088958A3 publication Critical patent/WO2019088958A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne en particulier l'utilisation d'un agent actif antidiabétique présent dans les fruits du genêt épineux (Paliurus spina-christi Mill.) déterminé capable de concurrencer les médicaments antidiabétiques oraux dans le traitement de patients diabétiques.
PCT/TR2018/050591 2017-10-12 2018-10-12 Utilisation du genêt épineux en tisane pour le traitement du diabète Ceased WO2019088958A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201715541 2017-10-12
TR2017/15541 2017-10-12

Publications (2)

Publication Number Publication Date
WO2019088958A2 WO2019088958A2 (fr) 2019-05-09
WO2019088958A3 true WO2019088958A3 (fr) 2019-07-11

Family

ID=66331448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050591 Ceased WO2019088958A2 (fr) 2017-10-12 2018-10-12 Utilisation du genêt épineux en tisane pour le traitement du diabète

Country Status (1)

Country Link
WO (1) WO2019088958A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115957143A (zh) * 2022-08-24 2023-04-14 广州辛选供应链有限公司 一种抑制AGEs、抗衰老去黄提亮肌肤的组合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895510A (zh) * 2006-06-18 2007-01-17 芮育健 熟地山萸肉茯苓温阳滋肾治疗糖尿病的新方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895510A (zh) * 2006-06-18 2007-01-17 芮育健 熟地山萸肉茯苓温阳滋肾治疗糖尿病的新方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANTULUK Z.C. ET AL.: "Halk arasinda diyabete kargi kullanilan bitkiler (Tiirkiye) 2", HACETTEPE UNIVERSITESI ECZACILIK FAKIILTESI DERGISI, vol. 32, no. 2, 2012, pages 179 - 208, Retrieved from the Internet <URL:https://docplayer.biz.tr/349918-Halk-arasinda-diyabete-karsi-kullanilan-bitkiler-turkiye-ii.html> *
KALUVALA, R ET AL.: "Effect of Naringenin on streptozotocin induced diabetes in rats", INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH., vol. 4, January 2012 (2012-01-01), pages 40 - 43 *
MAHMOUD, MOSADDEGH ET AL.: "Study on the Effect of Paliurus spina-christi on Cholesterol, Triglyceride and HDL Levels in Diabetic Male Rats Fed a High Cholesterol Diet", IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, vol. 3, January 2004 (2004-01-01), XP055618916 *

Also Published As

Publication number Publication date
WO2019088958A2 (fr) 2019-05-09

Similar Documents

Publication Publication Date Title
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
WO2015165413A8 (fr) Nouveau conjugué anticorps-médicament stable, procédé pour le préparer, et son utilisation
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
WO2015077503A8 (fr) Composés inhibiteurs de l&#39;autotaxine
WO2014141210A3 (fr) Cellules souches de pulpe dentaire immatures multifonctionnelles et applications thérapeutiques
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
WO2017121646A8 (fr) Dérivés de 3-(carboxyéthyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-décane
MX2017006437A (es) Compuestos espiroisoquinolin-1,4&#39;-piperidinicos con actividad multimodal contra el dolor.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4523542A3 (fr) Produits laitiers humains utiles en soins pre- et post-operatoires
PH12020550050A1 (en) Novel acylated insulin analogues and uses thereof
WO2016191458A3 (fr) Compositions pharmaceutiques ayant un effet sur l&#39;état d&#39;oxydoréduction mitochondriale et méthodes de traitement associées
WO2016029136A8 (fr) 3-amidobenzamides et leurs utilisations pour augmenter les taux cellulaires d&#39;a3g
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2019003725A (es) Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB201117490D0 (en) Anti-inflammatory compounds
WO2019088958A3 (fr) Utilisation du genêt épineux en tisane pour le traitement du diabète
MX2018014136A (es) Derivados de tetrahidropirano y tiopirano que tienen actividad multimodal contra el dolor.
MA39009A (fr) Compositions pharmaceutiques comprenant un agent actif
WO2016032127A3 (fr) Nouveaux composés présentant des activités antioxydantes et anti-inflammatoires en raison de la concurrence avec lps pour se lier à tlr4, et leur utilisation médicale
WO2016144706A3 (fr) Composés inhibiteurs de l&#39;autotaxine et leurs utilisations
WO2015126151A3 (fr) Composition pour la cicatrisation de plaies comprenant de l&#39;extrait de massa medicata fermentata
WO2016007042A3 (fr) Epoxydes de 3-méthyl-6-(prop-1-ène-2-yl)cyclohex-3-ène-1,2-dione consistant en de nouveaux agents contre la maladie de parkinson et antispasmodiques
MX2012014799A (es) Composición medicinal, método de preparación y uso de la misma.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18871831

Country of ref document: EP

Kind code of ref document: A2